The global surgical robot systems market size was estimated at USD 11.48 billion in 2024 and is projected to grow at a CAGR of 12.4% from 2025 to 2030. The market is driven by several factors, such as technological advancement, the rising preference for minimally invasive procedures, improved outcomes, greater precision, and reduced human errors in surgical procedures. This development is a significant advancement in medical technology, combining innovation with a commitment to enhancing the safety and efficacy of surgical operations. Moreover, an increasing number of knee and hip replacement surgeries due to rising cases of osteoporosis and arthritis are anticipated to drive growth. For instance, according to data published by the Agency for Healthcare Research and Quality, over 450,000 total hip replacement surgeries are conducted annually in the U.S.
The rising demand for minimally invasive procedures has been a key driver for adopting surgical robot systems. Minimally invasive surgeries offer patients benefits such as shorter hospital stays, faster recovery times, lower risk of complications than traditional open surgeries, and reduced pain. Robotic systems enable surgeons to perform complex procedures through small incisions with greater precision and control. For instance, in July 2024, AcuSurgical completed its first clinical study with the Luca surgical robot for vitrectomy procedures. This robotic system provides precision of up to 10 microns. The system is able to allow surgeons to treat more patients, expedite training, address a broader range of pathologies, and increase safety and accuracy.
Furthermore, Various surgical robot systems market companies are expanding into Ambulatory Surgical Centers (ASCs) to capitalize on the growing demand for minimally invasive procedures in outpatient settings. This expansion is driven by the cost-efficiency and faster recovery times associated with ASCs, making them attractive alternatives to traditional hospital-based surgeries. Companies such as Intuitive Surgical, Johnson & Johnson’s Ethicon, and Medtronic actively target ASCs with compact, cost-effective robotic systems tailored for smaller facilities. The trend is further supported by advancements in robotic technology, such as AI integration and modular designs, which enhance procedural accuracy and adaptability in outpatient environments.
The major driver for surgical robot systems is the ability to improve patient surgical outcomes. Robotic-assisted surgery increases accuracy and precision during procedures, reducing blood loss. Robotic surgery results in better clinical outcomes and higher patient satisfaction than traditional methods. For instance, in July 2024, Sovato Health Inc., with its Sovato remote surgery platform, conducted a series of remote robotic-assisted surgical procedures. Seven surgeons across four specialties conducted hysterectomy, nephrectomy, cholecystectomy, and colectomy procedures as part of the preclinical tests on pigs across about 500 miles between Lincoln and Chicago, Neb.
Another significant driver for the industry is surgical robot systems’ potential to reduce human errors in the operating room. Robotic systems offer steady hands and precise movements that minimize human error risk during delicate surgical procedures. Robotic platforms help mitigate factors such as hand tremors or fatigue that affect procedural accuracy by providing surgeons with enhanced visualization and dexterity. For instance, over 1,700 da Vinci Systems are installed in healthcare settings across the globe, and over 775,000 patients across the globe have had a da Vinci procedure.
The rising number of regulatory approvals and patent grants propels the surgical robot industry by accelerating product launches and technological progress. Streamlined pathways from authorities such as the FDA and CE Mark have enabled the rapid entry of advanced surgical systems. Simultaneously, increased patent filings highlight ongoing innovation, such as AI-driven enhancements and minimally invasive designs. For example, CMR Surgical holds 1,053 global patents across 272 unique families, with 979 active patents showcasing continuous R&D efforts driving global market expansion and competition.
This product will be delivered within 1-3 business days.
The rising demand for minimally invasive procedures has been a key driver for adopting surgical robot systems. Minimally invasive surgeries offer patients benefits such as shorter hospital stays, faster recovery times, lower risk of complications than traditional open surgeries, and reduced pain. Robotic systems enable surgeons to perform complex procedures through small incisions with greater precision and control. For instance, in July 2024, AcuSurgical completed its first clinical study with the Luca surgical robot for vitrectomy procedures. This robotic system provides precision of up to 10 microns. The system is able to allow surgeons to treat more patients, expedite training, address a broader range of pathologies, and increase safety and accuracy.
Furthermore, Various surgical robot systems market companies are expanding into Ambulatory Surgical Centers (ASCs) to capitalize on the growing demand for minimally invasive procedures in outpatient settings. This expansion is driven by the cost-efficiency and faster recovery times associated with ASCs, making them attractive alternatives to traditional hospital-based surgeries. Companies such as Intuitive Surgical, Johnson & Johnson’s Ethicon, and Medtronic actively target ASCs with compact, cost-effective robotic systems tailored for smaller facilities. The trend is further supported by advancements in robotic technology, such as AI integration and modular designs, which enhance procedural accuracy and adaptability in outpatient environments.
Industry Perspectives
Several companies and experts have expressed their support for the transition towards ASCs:
- Intuitive Surgical, a leader in robotic surgery systems, emphasizes that expanding into ASCs allows for broader access to robotic-assisted procedures. Their systems are designed to improve operational efficiency while maintaining high standards of patient care.
- Medtronic, another major player in the surgical robotics field, has noted that the integration of robotic systems into ASCs can streamline workflows and enhance patient throughput without compromising safety or quality.
- Surgical Care Affiliates (SCA) has reported that the adoption of robotic technology in their ASCs has led to improved patient satisfaction scores due to quicker recovery times and less postoperative pain.
The major driver for surgical robot systems is the ability to improve patient surgical outcomes. Robotic-assisted surgery increases accuracy and precision during procedures, reducing blood loss. Robotic surgery results in better clinical outcomes and higher patient satisfaction than traditional methods. For instance, in July 2024, Sovato Health Inc., with its Sovato remote surgery platform, conducted a series of remote robotic-assisted surgical procedures. Seven surgeons across four specialties conducted hysterectomy, nephrectomy, cholecystectomy, and colectomy procedures as part of the preclinical tests on pigs across about 500 miles between Lincoln and Chicago, Neb.
Another significant driver for the industry is surgical robot systems’ potential to reduce human errors in the operating room. Robotic systems offer steady hands and precise movements that minimize human error risk during delicate surgical procedures. Robotic platforms help mitigate factors such as hand tremors or fatigue that affect procedural accuracy by providing surgeons with enhanced visualization and dexterity. For instance, over 1,700 da Vinci Systems are installed in healthcare settings across the globe, and over 775,000 patients across the globe have had a da Vinci procedure.
The rising number of regulatory approvals and patent grants propels the surgical robot industry by accelerating product launches and technological progress. Streamlined pathways from authorities such as the FDA and CE Mark have enabled the rapid entry of advanced surgical systems. Simultaneously, increased patent filings highlight ongoing innovation, such as AI-driven enhancements and minimally invasive designs. For example, CMR Surgical holds 1,053 global patents across 272 unique families, with 979 active patents showcasing continuous R&D efforts driving global market expansion and competition.
Global Surgical Robot Systems Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, the analyst has segmented the global surgical robot systems market report based on component, application, end-use, and region:Component Outlook (Revenue, USD Million, 2018 - 2030)
- Surgical Robot
- Laparoscopic robotic systems
- Orthopedic robotic systems
- Neurosurgical robotic systems
- Other robotic systems
- Surgical Robotic Accessories
- Surgical Robotic Services
Application Outlook (Revenue, USD Million, 2018 - 2030)
- Orthopedics
- Neurology
- Gynecology
- Urology
- Others
End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals & clinics
- Ambulatory surgery centers
Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Argentina
- MEA
- South Africa
- Saudi Arabia
- UAE
- Kuwait
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Surgical Robot Systems Market Variables, Trends & Scope
Chapter 4. Surgical Robot Systems Market Segment Analysis, By Component, 2018-2030 (USD Million)
Chapter 5. Surgical Robot Systems Market Segment Analysis, By Application, 2018-2030 (USD Million)
Chapter 6. Surgical Robot Systems Market Segment Analysis, By End Use, 2018 - 2030 (USD Million)
Chapter 7. Surgical Robot Systems Market Segment Analysis, By Region, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Intuitive Surgical
- THINK Surgical, Inc.
- Smith+Nephew
- Medtronic
- Stryker
- Zimmer Biomet
- CMR Surgical
- Asensus Surgical US, Inc.
- Renishaw PLC.
- MOON Surgical
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | January 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 11.48 Billion |
| Forecasted Market Value ( USD | $ 23.13 Billion |
| Compound Annual Growth Rate | 12.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
